Immuno-oncology Clinical Trials Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Immuno-oncology Clinical Trials Market size was estimated at USD 5.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 13% from 2022 to 2028.

Immunotherapy is becoming increasingly available in clinical trials for early-stage cancer or as a first-line treatment option as clinical research progresses rapidly. Targeted antibodies, cancer vaccines, adoptive cell transfer, oncolytic viruses, checkpoint inhibitors, cytokines and adjuvants are all examples of cancer immunotherapy. Because they use living things to fight disease, immunotherapy is a type of biotherapy (also called biotherapy or biological response modulator (BRM) therapy). Gene therapy is an immunotherapy treatment that uses genetic engineering to improve the ability of immune cells to fight cancer.

Market Segments

Immuno-oncology Clinical Trials – By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

Immuno-oncology Clinical Trials – By Design

• Interventional trials
• Observational trials
• Expanded access trials

Immuno-oncology Clinical Trials – By Indication

• Solid tumors
• Hematological cancer

Key Players

• ICON, Plc
• IQVIA Holdings
• BioNtech
• Covance, Inc.
• IO BIOTECH
• MEDPACE
• Exscientia
• Syneous Health
• Astrazeneca
• Novartis

Scope of the Report

The research study analyzes the global Immuno-oncology Clinical Trials industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Immuno-oncology Clinical Trials Market Report

1. What was the Immuno-oncology Clinical Trials Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Immuno-oncology Clinical Trials Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Immuno-oncology Clinical Trials Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.